Wednesday, June 15 2016 23:28 EEST
Watch: FDA Approves the AspireAssist, a Minimally-Invasive Alternative to weight loss
FDA, approve, AspireAssist, weight loss, procedure, medicine, medical news, stomach, surgery, overweight, video, implant, system

Aspire Bariatrics, Inc., announced today that the US Food & Drug Administration has approved the 'AspireAssist' System, an endoscopic alternative to weight loss surgery for people with moderate to severe obesity.

The AspireAssist procedure is indicated for adults with a BMI of 35 to 55 who have not succeeded with more conservative therapies.

The AspireAssist system consists of a thin tube implanted in the stomach, connecting to an outside port on the skin of the belly. About 20 minutes after finishing a meal, users connect the port to an external device, which drains some of the recently-consumed food into the toilet.

latest news